Notable Labs Ltd reports results for the quarter ended in June - Earnings Summary

Notable Labs

15/08/2024 06:07

* Notable Labs Ltd  NTBL.OQ  reported a quarterly adjusted
loss
of 55 cents​​ per share for the quarter ended in June.  The lone
analyst forecast for the quarter was for a loss of 43 cents per
share. 
    * Revenue was $2.00 thousand​; analysts expected zero. 
    * Notable Labs Ltd's reported EPS for the quarter was a loss
of 55
cents​.
    * Notable Labs Ltd shares had fallen by 20.6% this
quarter and
lost 73.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Notable Labs Ltd
is $9.00 
This summary was machine generated from LSEG data August 15 at
05:07 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jan. 1 0001       -0.43          -0.55          Missed
 Mar. 31 2024      -0.39          -0.42          Missed
 Dec. 31 2023      -0.43          -5.46          Missed
 Sep. 30 2023      -0.41          -0.48          Missed